INTERNATIONAL PATENT: F. HOFFMANN-LA ROCHE AG, GENENTECH INC., HOFFMANN-LA ROCHE INC. FILES APPLICATION FOR "USE OF ATR INHIBITORS IN COMBINATION WITH ANTI-PD(L)1 THERAPY"

GENEVA, Nov. 17 -- F. HOFFMANN-LA ROCHE AG (Grenzacherstrasse 1244070 Basel), GENENTECH INC. (1 DNA WaySOUTH SAN FRANCISCO, California 94080), HOFFMANN-LA ROCHE INC. (150 Clove RoadSuite 8Little Falls, New Jersey 07424) filed a patent application (PCT/EP2025/061980) for "USE OF ATR INHIBITORS IN COMBINATION WITH ANTI-PD(L)1 THERAPY" on Apr 30, 2025. With publication no. WO/2025/233224, the details related to the patent application was published on Nov 13, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): AL-SAKAFF, Nedal (c/o F. Hoffmann-La Roche AGGrenzacherstrasse 1244070 Basel), ANTIC, Vlad...